JOHNSON & JOHNSON Proceeds from Debt 2007-2026 | JNJ
Beta
What is JOHNSON & JOHNSON's current proceeds from debt?
JOHNSON & JOHNSON (JNJ) annual proceeds from debt for 2025 was $9.14B, a 37.21% increase from 2024. JOHNSON & JOHNSON proceeds from debt for the quarter ending March 29, 2026 was $0.
What was JOHNSON & JOHNSON's proceeds from debt in 2024?
JOHNSON & JOHNSON annual proceeds from debt for 2024 was $6.66B, a Infinity% increase from 2023.
What was JOHNSON & JOHNSON's proceeds from debt in 2023?
JOHNSON & JOHNSON annual proceeds from debt for 2023 was $0, a 100.00% decline from 2022.
What is JOHNSON & JOHNSON's 4-year proceeds from debt CAGR?
JOHNSON & JOHNSON proceeds from debt grew at a compound annual growth rate (CAGR) of 5.31% from FY2021 to FY2025, going from $7.43B to $9.14B over 4 years.
Proceeds from Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+397.4%
FY2019
$3.0M
→
FY2025
$9.14B
07081011121314161718192122232425
5 years selected
Proceeds from Debt History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.14B | +37.2% | 10-K |
| FY2024 | $6.66B | - | 10-K |
| FY2023 | $0 | -100.0% | 10-K |
| FY2022 | $5.0M | -99.9% | 10-K |
| FY2021 | $7.43B | +247600.0% | 10-K |
| FY2019 | $3.0M | -40.0% | 10-K |
| FY2018 | $5.0M | -99.9% | 10-K |
| FY2017 | $8.99B | +11889.3% | 10-K |
| FY2016 | $75.0M | -96.4% | 10-K |
| FY2014 | $2.10B | -41.8% | 10-K |
| FY2013 | $3.61B | +7915.6% | 10-K |
| FY2012 | $45.0M | -96.0% | 10-K |
| FY2011 | $1.12B | +12322.2% | 10-K |
| FY2010 | $9.0M | -99.5% | 10-K |
| FY2008 | $1.64B | -67.9% | 10-K |
| FY2007 | $5.10B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →